Showing 18 posts in Medical Marijuana.
Ohio Physician's Guide to Cannabis Compliance 2.0: Budding Issues for Ohio’s Medical Marijuana Physicians
Co-Author: Maxwell Williams
Cash only? Informed consent forms? Waivers of liability? The original Ohio Physician’s Guide to Cannabis Compliance (Part 1) was created to give Ohio M.D.s and D.O.s a starter pack for understanding Ohio’s Medical Marijuana Law, including the distinction between a prescription and a recommendation, and the all-important Rohrabacher Amendment, which requires strict compliance with state law to attempt to avoid prosecution under federal law. However, as more physicians obtain an Ohio Certificate to Recommend medical marijuana, deeper issues must be understood to limit liability associated with Ohio’s medical marijuana law and ensure legal compliance before designing a medical marijuana practice. Read More ›
“Grandma’s tremors appear to have gotten worse lately. She mentioned she wants to try medical marijuana oil; can she use that in the nursing home?” “Do you think those ‘special’ gummy bears could help mom’s chronic back pain?” Read More ›
Ohio doctors can now apply to become certified to recommend medical marijuana for treatment. The Ohio Medical Marijuana Control Program released a statement on Monday, March 19, 2018, stating that the State Medical Board of Ohio is now accepting applications for a certificate to recommend. Read More ›
The West Virginia Medical Cannabis Advisory Board (“Advisory Board”) met on February 6, 2018, to review and consider comments made to proposed rules governing growers, processors, dispensaries, participating physicians and patients wishing to participate in the medical cannabis program. Read More ›
Physicians interested in recommending medical marijuana are already completing the two hours of continuing medical education credit necessary before applying for a Certificate to Recommend from the State of Ohio. Read More ›
To Kentucky, the grass must have literally been greener on the other side. After Kentucky lawmakers watched their neighbors in Ohio and West Virginia enact medical marijuana laws, they introduced a 65-page bill at the Kentucky statehouse Thursday morning to legalize medical marijuana. Read More ›
In November of 2017, United States Attorney General Jeff Sessions announced that the Department of Justice (DOJ) would abide by the Rohrabacher–Blumenauer Amendment which has been interpreted as prohibiting the use of federal dollars to prosecute marijuana-industry participants in specific states that have legalized medical marijuana. Read More ›
On December 14, 2017, the West Virginia Medical Cannabis Advisory Board announced: (1) the results of informal surveys to gauge patient need and physician interest in participation in the new medical cannabis program scheduled to be rolled out July 1, 2019; and (2) proposed rules to govern the implementation of medical cannabis programs in West Virginia. Read More ›
It’s already a stressful time of year, but for those vying for a license to convert marijuana plants into edibles, patches and oils, things have been thrust into overdrive. Read More ›
Under the Obama administration, the Department of Justice (DOJ) placed a low priority on pursuing charges against individuals and entities complying with state-sanctioned medical marijuana programs. However, under President Trump and his appointee, Attorney General Jeff Sessions... Read More ›
Ask the Blogger
Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.
Brian F. Higgins is an associate in FBT's regulated business group with a focus on health care, and he has a history as corporate counsel to Medpace, Inc., a pharmaceutical clinical research organization.